In the 2023-2024 season, VfB Stuttgart finished with 73 points. At the same time, Bayern Munich lost 2-4 to Hoffenheim. Stuttgart finished the season in second place, pushing Munich to third. Stuttgart also qualified for the Champions League.

The star of Stuttgart’s “breakout” was striker Serge Girassi. After a multi-goal performance in the league final, leading his team to a 4-0 victory, Girassi went on to score 28 goals in 28 league games, averaging nearly one goal per game.

Teams are interested in Girassi, and not just because of his goalscoring prowess, but also because of his buyout clause, which makes him seem like a bargain compared to his goalscoring prowess. According to reports from various local media outlets, Girassi could cost around €18 million ($26.8 billion). This is a bargain when you consider the transfer fees of players in the recent transfer market.

Given the situation, almost every club looking to bolster their attacking ranks was interested in Girassi, with Dortmund actively courting the player, and on March 27, Fabrizio Romano, a journalist well versed in the European transfer market, announced on his personal social media account that “Serge Girassi is heading to Dortmund” with the signature phrase “HERE WE GO! It was a done deal.

There was a twist.

Girassi was found to have a medical issue. Giroud underwent medical tests at Dortmund, but the move was halted.

“Dortmund have announced that an injury has been found on Giroud’s body that needs to be further confirmed,” Germany’s Sky Sports reported. The club plans to investigate this further and seek further medical advice.”

At the time, 메이저사이트 Sky Sports reported that “the injury will not be as ‘dramatic’ as feared. After an initial examination, the doctor has deemed the injury manageable with further treatment,” but the transfer has been suspended for now.

“What is certain is that Dortmund will not sign an unhealthy Giroud,” Bild said, “The club hierarchy remembers the case of Sébastien Alli. It was a tragic story.”

Prior to the start of the 2022-2023 season,

Dortmund signed Alli to replace Elling Holland, who left for Manchester City. The problem was that Alli was diagnosed with testicular cancer just before the start of the season. He was fortunate to overcome the disease, but he never really got going.

Patrick Berger, a journalist familiar with the German transfer market, reported on Wednesday that “Girassi has left Dortmund and returned to France. He will be in France for personal training and rehabilitation.”

Berger continued, “According to the results of the examination, Girassi will miss four weeks due to treatment, even if he returns to Dortmund, which means he will miss the preseason. The injury is fortunately not serious and appears to be treatable. We will carry out further tests and will not make a decision on the player’s future.”